Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality, but it’s also highly manageable with early recognition, evidence-based treatment, and coordinated care. This guide...
In a randomized, placebo-controlled study, azelastine nasal spray significantly lowered the incidence of polymerase chain reaction-confirmed SARS-CoV-2 infections and reduced overall respiratory viral...
In a randomized controlled trial, enteral propranolol significantly lowered sedative requirements and improved target sedation without increasing adverse events.
A retrospective review of patients undergoing elective dental procedures found that dexmedetomidine alone was more often associated with oxygen desaturation, while combining dexmedetomidine with ketamine...
Postdischarge ondansetron cut the risk of moderate-to-severe gastroenteritis in children by half, without increasing adverse events or health care use.
A pooled analysis of more than 1300 patients followed for up to 4 years found that baricitinib maintained a stable safety profile, with low rates of serious adverse events, no new safety concerns, and no...
Late-window alteplase improved 90-day independence in perfusion-selected ischemic stroke, with higher symptomatic intracranial hemorrhage and no mortality difference.
A retrospective cohort study found that patients undergoing outpatient GI procedures who received opioids intra- or post-operatively reported lower pain scores and fewer instances of postoperative nausea...
In an FDA panel held on July 21, 2025, experts discussed the nuances of risk-benefit counseling and stronger warnings for selective serotonin reuptake inhibitors (SSRIs) to ensure informed consent among...
